April 24th 2025
A pilot study reveals a dual-length microneedle RF device effectively reduces neck wrinkles by 35%, enhancing skin hydration and elasticity with minimal downtime.
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Revolutionizing Atopic Dermatitis (RAD) Conference 2025
June 6-7, 2025
Register Now!
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
July 26, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
Novel filler found safe, durable
December 1st 2004San Diego - Results from a U.S. Food and Drug Administration pivotal trial demonstrate that the injectable wrinkle filler Artecoll, composed of polymethylmethacralate (PMMA) microspheres (20 percent) suspended in an ultra-purified collagen carrier (80 percent) is an equally safe, but longer-lasting, alternative to bovine collagen for the cosmetic correction of a variety of facial contour defects, Steven R. Cohen, M.D., tells Dermatology Times.
Controversial mesotherapy: Could it be the next Botox?
December 1st 2004National report - Some physicians swear by it. Others call it "bogus." Still, mesotherapy glitters with a bit of the star power that lights up one of its better-known advocates, singer Roberta Flack. Hundreds of U.S. physicians now offer mesotherapy treatments - injections of homeopathic remedies, supplements, drugs or other substances into the mesoderm - starting at $200 to $300 per session.
Aging baby boomers focus on skin, but face long waits for office visits
December 1st 2004National report - As the baby boom generation ages, its members will want what they have always wanted from dermatologists - to look younger longer. At the same time, they'll encounter more age-related medical problems, while the supply of dermatologists who can meet these needs continues to dwindle.
Antibiotic resistance: Derms debate significance
November 1st 2004National report - Many dermatologists' attitudes toward antibiotic resistance can be summarized as: "I don't see it in my practice, so it's not my problem."But a growing number of practitioners are recognizing the potential significance of the problem, particularly when it comes to treating common conditions, including acne.
Hylaform Plus wins FDA nod for wrinkle correction
November 1st 2004National report - The U.S. Food and Drug Administration (FDA) has approved Hylaform Plus (Hylan-B gel), a large-particle-size hyaluronic acid-based dermal filler indicated for the correction of moderate to severe facial wrinkles and folds.
Cosmeceuticals: Youth in a jar?
November 1st 2004National report - Despite a long history of ambitious goals and promises of over-the-counter rejuvenation, the field of antiaging topicals remains young. Still, the science is improving, although many dermatologists contend that many claims are short on evidence.
Can stem cells turn back the clock?
November 1st 2004Boston - Stimulating the body to regenerate itself and repair the damage of aging is the latest goal of anti-aging medicine. One of the founding members of the American Academy of Anti-Aging Medicine and the first president of the American Board of Anti-Aging Medicine, Vincent C. Giampapa, M.D., F.A.C.S., says research shows that, if given the right conditions, stem cells in the subcutaneous layer of the skin can develop into healthier tissue and inhibit the aging process.
Botox effective perioral therapy
November 1st 2004Stanford, Calif. - By nearly all accounts, nothing beats Botox in the upper face for quickly, consistently and noninvasively offering patients the most bang for their rejuvenation buck. Yet, physicians are now finding new indications farther down the face - particularly in the perioral area, which has proven resistant to surgical treatment.
Europe leads U.S. in UV protection
November 1st 2004Zurich - Sunscreens containing ultraviolet B (UVB) filters protect against sunburn, but not against ultraviolet A (UVA) rays, which are deemed responsible for skin cancer. So far, there have been only a limited number of products offering UVA protection in the United States. Possibly the most effective ingredient available for UVA protection is Parsol 1789 (avobenzone), but its photo-instability makes it a less than optimum product in trying to achieve broad spectrum UV protection.
Photodamaged skin benefits from combination therapy
November 1st 2004Dallas - Dermatologists who are using either intense pulsed light laser or pulsed dye laser therapy to treat photodamaged skin should use it concurrently with a topical retinoid according to a randomized study performed by Emil A. Tanghetti, M.D., of the Center for Dermatology and Laser Surgery, in Sacramento, Calif.
Low-level laser evidence inconclusive
October 1st 2004Dallas - Patients' interest in minimally invasive treatments could bode well for the future of low-level laser therapy (LLLT) in the United States, but only if its efficacy can be proven. And current research results are inconclusive, says Murad Alam, M.D., chief, section of cutaneous and aesthetic surgery, department of dermatology, Northwestern University.
Low-level laser tx promotes healing
October 1st 2004National report - Low-level laser therapy (LLLT) effectively promotes wound healing without causing burn to adjacent tissue, according Lars Hode, D.Sc. The operative principle, known as photobiomodulation, is particularly useful in treating decubitus ulcers, typical of people with diabetes and frail elderly patients who spend long hours in bed. It also has cosmetic applications and can be used for scar revision, as in the treatment of acne scars.